The study will aim to recruit 20 women with PCOS and 20 controls and measure the effect of serum from these women on cell proliferation and molecular pathways in human EC cell lines, compared with IGF-1 and IGF-1 antagonists. This evidence concerns the gene IGF1 and polycystic ovary syndrome.